DefiLlama Now Tracking Bio Protocol on Ethereum and Base: A Boost for DeSci Projects
Explore DefiLlama's latest addition of Bio Protocol, a decentralized science platform revolutionizing biotech funding on Ethereum and Base, with over $20M in TVL.
Explore DefiLlama's latest addition of Bio Protocol, a decentralized science platform revolutionizing biotech funding on Ethereum and Base, with over $20M in TVL.
Dive into the recent updates from Bio Protocol ($BIO), featuring a major listing on Upbit, strategic partnerships with Binance Labs and Pfizer Ventures, and advancements in decentralized science funding.
Dive into Bio Protocol's strategic infrastructure upgrades timed with its Upbit exchange listing, exploring if $BIO is gearing up for sustainable growth in the DeSci space amid Korean market hype.
Dive into the latest crypto mindshare shifts where AI surges ahead, DeSci eyes a rebrand to DeScAi driven by Bio Protocol, and what it means for sectors like memes and DeFi.
Bio Protocol just landed $6.9M in funding from heavyweights like Animoca Brands and Arthur Hayes' Maelstrom Fund. Dive into how their AI 'BioAgents' could slash drug discovery timelines and supercharge decentralized science on blockchain.
Dive into Aubrai's impressive $180K fees on $20M volume, 67% win rate, and autonomous hypothesis generation—unlocking the future of AI agents in blockchain and DeSci.
Bio Protocol, a cutting-edge DeSci platform revolutionizing biotech funding with AI and blockchain, gets spotlighted on BSC News. Dive into its $6.9M seed round, $BIO token, and why it's a must-watch in crypto.
Dive into Bio Protocol's recent $6.9 million funding round led by Arthur Hayes' Maelstrom Fund, and hear from CEO Paul Kohlhaas on how AI and crypto are transforming decentralized science for faster biotech breakthroughs.
In a candid clip from The Rollup, Bio Protocol CEO Paul Kohlhaas explains how desperate scientists and partnerships with AI powerhouses like Sakana AI give his DeSci project a massive competitive advantage in the blockchain world.
Explore how AI agents in projects like Aubrai are outpacing prediction markets in innovation, as highlighted in S4mmyEth's viral tweet on Bio Protocol's DeSci advancements.